Molecular Subtyping for Prognosis Evaluation in Resected Pancreatic Adenocarcinoma

Clinical trial NCT05483257 · COMPLETED

Trial details

NCT number: NCT05483257
Sponsor: BAIYONG SHEN
Status: COMPLETED
Study type: OBSERVATIONAL

Pancreatic Cancer Resectable

Start date: 2018-03-14
Primary completion: 2020-08-03
Enrollment: 226

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.